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Retinitis pigmentosa (RP) is a leading cause of blindness worldwide and lacks effective clinical treatment.
Stem cell-based therapy offers a novel experimental therapeutic approach, based on the strategy that
transplanted progenitor cells can replace or rescue damaged photoreceptor cells. However, many factors
remain to be determined, for example, what is the optimal time to choose for targeting the host tissue
during the progression of the degeneration, what the characteristics and potential capacities in different
stem cells, do stem cells differentiate into functional daughter cells, and to what degree can host retinal
function be restored? We have used Royal College of Surgeons rats and light-induced retinal degener-
ation minipigs as animal models of retinitis pigmentosa to study the effectiveness of cell transplant
therapies and the functional capacity of the host retina. Stem cells from rat retina and bone marrow,
neonatal pig, and human fetal retina have been investigated to ﬁnd the proper donor cells. The dedif-
ferentiation and then redifferentiation of Müller cells following retinal stem cell transplantation may
contribute to host visual function and presents a promising line of research.
Copyright  2012, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Retinitis pigmentosa (RP) is a group of inherited diseases in
which progressive photoreceptor dysfunctionis associated with cell
loss and eventual retinal atrophy.1 There are few effective clinical
treatments for RP, a disease that affects an estimated 1.5 million
individuals worldwide, or other retinal degenerative diseases such
as age-related macular degeneration, which is a leading cause of
blindness in older individuals.2 A variety of experimental therapies
are under investigation aimed at repairing or rescuing impaired
vision, including gene therapy and retinal transplantation.
However, gene therapy has proven to be difﬁcult due to problems
involved in ﬁnding key target genes in the large number of RP-
related genes, and the ﬁnding that gene therapy can be only used
in the early stages of RP.3 These limitations have recently made the
renewed prospect of retinal transplantation or prosthesis more
attractive. Various cells, tissues, and devices have been investigated
in retinal transplantation, including photoreceptor cells, retinal
pigment epithelial (RPE) cells, embryonic or neural stem cells, bone
marrow-derived stem cells, retinal stem/progenitor cells, fetal
neuroretina (with or without RPE), and retinal prostheses.4e6thwest Eye Hospital, Third
a.
e Ophthalmologic Society of TaiwHowever, there are still many points that require clariﬁcation,
some of which are as follows. First, what is the best timing to target
host degeneration that can produce efﬁcacious functional rescue
when using subretinal implantation? Second, what are the char-
acteristics and potential rescuing capacities of different donor
cells? Third, can donor cells differentiate into functional daughter
cells with appropriate electrophysiological function? Last but not
least, how does the graft restore host retinal function after sub-
retinal implantation in RP? We studied these questions in the
search for a possible clinical treatment strategy of RP, by using a rat
retinal degeneration model, the Royal College of Surgeons (RCS)
rats, and light-induced retinal degeneration in minipigs. Our ﬁnd-
ings are discussed in the following review.
2. Cell therapy for retinitis pigmentosa in animal models
2.1. Surviving ganglion cellsda guide for retinal degeneration stem
cell therapy
We investigated the modiﬁcations in the density and electro-
physiological changes of retinal ganglion cells (RGCs) in RCS rats
during retinal degeneration, to see whether there were functional
surviving inner layer cells during retinal degeneration. At postnatal
week seven (Pn7) and Pn8, the density of the RGC was about 71% of
that at Pn3, and by Pn12 this had fallen to w46%. Thus, although
there is a dramatic loss of ganglion cells, a substantial proportion ofan. Published by Elsevier Taiwan LLC. All rights reserved.
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RGC action potential discharge patterns in RCS rats: single, tran-
sient, and sustained ﬁring. The main discharge pattern was single
ﬁring between Pn1 and Pn2, followed later by transient and sus-
tained ﬁring patterns. However, during later stages of retinal
degeneration at Pn7e8, 26.7% RGCs lack action potentials in RCS
rats, and this proportion had increased to 63.2% by Pn9e12. This
suggested that functional RGCs were maintained during the early
stages of retinal degeneration, but this was not sustained, even
though morphological changes were not apparent.8 By a new GFP
expressing rd10 mutant mouse which is a model of autosomal
recessive RP, RGCs showed remarkable preservation of structure,
survival, and projections to higher visual centers even after severe
damage of photoreceptors.9 However, all RGCs types showed an
undersized dendritic tree, possibly as a consequence of altered
visual input.10 A recent study displayed that in rd10 mouse bipolar
cell processes extended into the inner nuclear layer and ganglion
cell layer by postnatal month 9.5, whichmay contribute to the long-
term survival of RGCs.11 Some studies also indicated that in the
remodeling of retinal degeneration, unlike second-order neurons
such as bipolar and horizontal cells, RGCs appear as a considerably
stable population of cells, potentially forming a favorable substrate
for restoring vision in RP individuals throughcell therapy.12e22
2.2. Fifteen days ion channel maturation for retinal stem
cellsdbeneﬁt for thought in transplantation protocols
The characteristic of the donor stem cells is a key issue when
attempting to rescue function in RP retinas. The functionality of the
donor cells can be reﬂected not only by antigen markers, but also
cellular activity. Cultured retinal stem cells (rSCs) can differentiate
and produce action potentials in vitro showing that the maturation
of electrophysiological properties after at least 15 days under
culture conditions (Fig. 1).23 These neuron-like cells, presumptive
RGCs, developed active electrophysiological features, including
inward sodium currents and outward potassium currents. During
the process of stem cell differentiation, voltage-dependent ion
channels gradually developed in a time-dependent manner and
ultimately supported mature action potential ﬁring similar to thatFig. 1. Differentiated retinal stem cells can generate action potentials. Responses are
shown to a 1-second 80-pA intracellular current pulseduring current-clamped
recordings after speciﬁed day in vitro (DIV) culture conditions. Evoked action poten-
tials could not be reliably generated in the cells before DIV10. At DIV10, a broad but
shallow single evoked action potential could be recorded, and by DIV25 the action
potentials resembled those in the comparison group and had a relatively mature ﬁring
pattern. (Note. From “Differentiation and production of action potentials by embryonic
rat retina stem cells in vitro,” by L.F. Chen, Z.Q. Yin, S. Chen, Z.S. Chen, 2008, Invest
Ophthalmol Vis Sci, 49, p. 5144e50. With copyrights permission).observed in the cultured postnatal cells. Importantly, action
potentials could be induced but also developed spontaneously.
Knowledge of the appearance of voltage-dependent ion channels
during development provides a time window for functional stem
cell maturation, and this will help to improve the success rate in
transplantation protocols if functional recovery is to be achieved.
2.3. Three types of rat stem cells and their subretinal
transplantation
We found that three types of stem cells could be incorporated
into the degenerating retina and differentiated into rhodopsin
positive cells: rat optic cup derived retinal stem cells (OC-rSCs) at
embryonic day 12.5, rSCs fromembryonic day 17 of LongeEvans rats
pretreated by BDNF (rSCs-BDNF), and rat bonemarrow stromal cells
(rBMSCs) pretreated with ﬁbroblast growth factor (bFGF).
2.3.1. Rat optic cup derived retinal stem cells at embryonic day 12.5
OC-rSCs are easily enriched to 92% by three passages, have
a normal diploid karyotype, and exhibit no obvious differences in
proliferative rate during eight passages; however, a large number of
E12.5 rat embryos are required. To verify that the neurogenic versus
gliogenic properties were similar in vitro and after transplantation,
OC-rSCs were transfected with the Enhanced Green Fluorescent
Protein-plasmid (EGFP-plasmid) after passage three and then trans-
planted into the subretinal space of RCS rats. OC-rSCs were incorpo-
rated into the degenerated retina and had differentiated into
rhodopsin positive cells.24 Although the number of double-labeled
rhodopsin positive cells was quite low, OC-rSCs offer greater poten-
tial for manipulating differentiation into speciﬁc retinal phenotypes.
2.3.2. Retinal stem cells from embryonic day 17 LongeEvans rats
pretreated by BDNF (rSCs þ BDNF)
RCS rats received injections of rSCs, stem cells induced by brain-
derived neurotrophic factor (rSCs þ BDNF), phosphate-buffered
saline (PBS), or BNDF alone.25 At 1, 2, and 3 months after subretinal
transplantation, we found both rSCs eyes and rSCs þ BDNF eyes had
thicker outer nuclear layers (ONLs) and better photoreceptor main-
tenance compared to PBS and BDNF injected eyes (p < 0.01) at each
time point. This suggested that the rate of photoreceptor degenera-
tion and cell death had slowed to some degree. However, outer
nuclear layer thickness in rSCs þ BDNF transplanted eyes was not
signiﬁcantly different from rSCs transplants alone, suggesting no
added beneﬁt from BDNF in terms of cell survival. Although the
electroretinogram (ERG) enhancement due to rSCs þ BDNF trans-
plantswasonlyapparent in the1stmonthafter theoperation, cellular
factors will play an important role in cell replacement therapy in
retinal disease by helping to obtain a better survival rate of grafted
cells, and by rescuing retinal neurons from further degeneration.
2.3.3. Rat bone marrow stromal cells pretreated with bFGF
Untreated rBMSCs and rBMSCs pretreated with bFGF (composed
of phenotypically differentiated retinal neurons) survived for 3
months following transplantation into the subretinal space of RCS
and normal control rats.26 The number of surviving cells in the
degenerating RCS rat retina was signiﬁcantly higher compared to
transplants in the normal rat retina. In RCS rats, the bFGF-pretreated
cell mixtures containing phonotypically differentiated cells had
greater survival rates and ability to migrate compared to the
untreated BMSCs. At 1 postoperative month, the latency and ampli-
tude of the Rod-ERG b wave showed signiﬁcantly more recovery in
transplanted rats compared to sham operated rats. A signiﬁcant
increase in theamplitude of theMax-ERGbwavewasalsoobserved1
and 2 months post-transplantation. However, by 3 months the
improvement in the Rod-ERG and Max-ERG b wave latency and
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a combination of bFGF with BNDF and neuronal growth factor can-
induce BMSCs to produce recoverin, PKC, andGFAP.27 Thus, this bFGF
treatment can transiently rescue cells from degeneration of the
photoreceptors in vivoand partly improve visual function after
transplantation for 1 and 2 months.
Therefore, the key elements for stem cells to restore retinal
function after subretinal transplantation are high purity, easy
access, and pretreatment with cell factors for better survival and
differentiation.
2.4. Retinal transplantation in minipigs by neonatal piggy retina or
human fetal retina with retinal pigment epithelium
Transplanting only the neuroretina or only the RPE has limited
restorative capacity.6,28 Fetal neuroretina with RPE is potentiallyFig. 2. Multifocal electroretinography (mfERG) analysis of the P1 and N1 wave in normal co
eyes with a graft after various survival times. The P1 wave amplitude density within rin
transplantation values. The N1 wave amplitude increased in central (rings 1 and 2) and
changes were characterized by two peaks over 8 months: 1st and 3rd to 5th months after th
*p < 0.05 eyes at the end of light-damage period versus light-damaged eyes with transplants
degeneration by human fetal retinal transplantation in minipigs,” by S.Y. Li, Z.Q. Yin, S.J. Chmore efﬁcacious because it preserves an intact microenvironment
or “stem cell niche” for the retinal stem/progenitor cells.29,30 We
developed a transplantation method with an w67% success ratio
in a large animal model, which may be similar to future methods
used in clinical practice.31,32 We examined the ability of intact
neonatal minipig and human fetal retina (neuroretina þ RPE) to
become incorporated into a degenerating retina, its fate after
transplantation, and its effect on the host retinal function.
Neonatal grafts maintained good viability after laser micro-
ablation from the choroid, in contrast to dispase enzyme dissec-
tion that appeared to damage the retina. A 12-month follow-up
showed that xenograft transplantation had not resulted in any
immunological rejection and thus was a safe technique. The
human fetal grafts survived and retained characteristics of
progenitor precursor cells, such as Chx10 labeling.Multifocal
electroretinography (mfERG) of the host retina showed that the P1ntrols (n ¼ 6), at the end of a light-damage period (n ¼ 32), and in the light-damaged
g 1 and the amplitude in rings 1 and 2 increased, compared with (A, B) their pre-
paracentral retina (rings 3e6) compared with (C) pre-transplantation values. These
e operation. ##p < 0.05: control eyes versus eyes at the end of light-damage period.
at 1, 2, 3, 5, and 8 months after surgery. (Note. From “Rescue from light-induced retinal
en, L.F. Chen, Y. Liu, 2009, Curr Eye Res, 34, p. 523e35. With copyrights permission).
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rings 1 and 2 (central retina) increased compared with their pre-
transplantation values (Figs. 2A and 2B). The N1 wave amplitude
increased in both central (rings 1 and 2) and paracentral retina
(rings 3e6) compared with pre-transplantation values (Fig. 2C).
The latency of N1 and P1 waves did not show signiﬁcant changes.
These mfERG changes were characterized by two peaks over 8
months: the P1 and N1 wave amplitudes, and P1 wave amplitude
density were enhanced in the 1st month after transplantation,
maintained in the 2nd month, but subsequently signiﬁcantly
increased in the 3rd and 5th months, and remained until the 8th
month. This improvement of host retinal function happened not
only in the transplanted area (rings 1 and 2) but also in the areas
adjacent to the grafts (rings 3e6) from the 1st to 8th months after
transplantation.Fig. 3. Increased retinal progenitor cells induced by retinal stem cell (rSC) transplantatio
labeling appears green, vimentin labeling appears red, and cell nuclei are blue (DAPI). After
and green) had increased by (A) day 60 (D60), (B) D90, and (C) D120, whereas in the PB
dihydrochloride hydrate. (Note. From “Increased Muller cell de-differentiation after graftin
Tian, T. Zhao, Y. Zeng, Z.Q. Yin ZQ, 2011, Tissue Eng Part A, 17, p. 2523e32.With copyrights p2.5. Contribution of Müller cells before and after retinal stem cells
transplantation
Müller cells are an integral and important glial component in the
normal function of the retina and form a vital part of the regenera-
tive process. Immunocytochemistry in the retina of RCS rats showed
that Müller cells express retinal progenitor cell markers in the reti-
nasof chronic degeneration.33 The number of Chx10 labeled Müller
cells dramatically increase in RCS rats that receive rSCs transplants
compared with controls (Fig. 3). However, subretinal trans-
plantation of chloromethyl-benzamidodialkylcarbocyanine pre-
treated rSCs in RCS rats, showed that only a small number of these
grafted cells retain their progenitor cell characteristics.34 We also
foundsomecells in the innernuclear layer that couldbe stainedwith
anti-recoverin rod and cone photoreceptor antibodies and werens. rSC transplants increased Müller cell dedifferentiation. In all micrographs, Chx10
rSCs transplantation, the number of dedifferentiated Müller cells (double-labeled red
S group, (DeF) few cells were double-labeled. DAPI ¼ 4,6-diamidino-2-phenylindole
g of retinal stem cell in the sub-retinal space of Royal College of Surgeons rats,” by C.
ermission).
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ﬁndings implied that some of these Müller cells could coexpress
a photoreceptor cell marker within and nearby the grafted area.
Therefore,Müller cells have thepotential to reenter the cell cycle and
can differentiate into host photoreceptor cells, thus restoring lost
retinal components. Further studies areneeded todeterminehow to
maintain the progenitor potential of Müller cells and how rSCs
transplants may augment this process of restoring cells, especially
photoreceptors, to the damaged retina.
3. Looking into the future
Many studies have shown that the visual function of the host
(retinal degeneration models) improved after transplantation of
rSCs.18,35e38 The methods used to determine these results included
ERG,multifocal electroretinogram, pupillary light reﬂex, visual
evoked potentials recorded from superior colliculus, and etholog-
ical changes due to alteration of visual function.
Our functional investigations show that transplantation of rSCs
could delay the progress of retinal degeneration in RCS rats and
light-induced retinal degeneration in minipigs. The visual function
of the whole retina was improved, not just the regions adjacent to
the transplant. Why does this happen? Some studies suggested that
graft may form synaptic connections with the host retina on the
basis of synaptophysin expression.18,39 Nevertheless, convincing
evidence for a fully functional connection that participates in the
transmission of visual signals has not been reported to date. We
found that transplantation of rSCs not only increased dedifferenti-
ation of Müller cells in the region of the transplant, but also
promoted Müller cells dedifferentiation in nontransplanted region.
Transplanted cells can differentiate into photoreceptors and at same
time, dedifferentiated Müller cells can differentiate into photore-
ceptors. That is, after rSC transplantation, not only the direct inter-
actionof graft cells and factorswithhost retinaoccurs, but also other
factors, such as cytokines released by graft cells, can increase the
capacity of host Müller cells to dedifferentiate. Further work needs
to done to show that Müller cell dedifferentiation and rediffer-
entiation is a common key event and a viable treatment target in
different retinal degeneration diseases. The extent to which rSC
transplants contribute to this process remains a major issue in
alleviating functional deﬁcits in retinal degenerative diseases.
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